Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications
Open Access
- 15 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cardiovascular Disorders
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12872-020-01514-0
Abstract
Inflammation and skeletal muscle wasting often coexist in elderly populations, but few studies have examined their relationship in elderly heart failure (HF) patients. This study examined the relationship between inflammation and increased skeletal muscle proteolysis, reduced skeletal mass and strength, and their prognostic implications in elderly HF patients (> 65 years) using a random forest approach. We prospectively enrolled consecutive elderly HF patients (n = 78) and age- and sex-matched control subjects (n = 83). We measured the interleukin (IL)-6, C-reactive protein (CRP), and B-type natriuretic peptide (BNP) levels, lower limb muscle mass and strength, and 6-min walk distance. The amount of muscle proteolysis was determined by urinary 3-methylhystidine, normalized by creatinine (3-MH/Cr). The composite endpoint was defined as all-cause death or hospitalizations due to worsening HF. Compared to controls, elderly HF patients had a significantly higher IL-6, CRP, BNP, and 3-MH/Cr, and exhibited a reduced lower limb muscle mass and strength. A correlation analysis demonstrated significant positive correlations between the inflammatory cytokine levels and 3-MH/Cr and BNP, and negative correlations with the lower limb muscle mass and strength, and 6-min walk distance. During a median follow-up of 2.4-years, 24 patients reached the endpoint. A random forest model revealed that inflammatory cytokines, skeletal muscle wasting, and the BNP had greater effects on the risk prediction. The algorithm achieved an area under the receiver operating characteristic curve of 0.887 (95% CI, 0.772–1.000). This study provided evidence of the association between inflammation and increased skeletal muscle proteolysis, reduced skeletal mass and strength, and their prognostic roles in elderly HF patients.Keywords
Funding Information
- Japan Society for the Promotion of Science (17K09533)
- Suzuken Memorial Foundation (2013)
This publication has 38 references indexed in Scilit:
- Isotopic decay of urinary or plasma 3‐methylhistidine as a potential biomarker of pathologic skeletal muscle lossJournal of Cachexia, Sarcopenia and Muscle, 2013
- Measuring protein breakdown rate in individual proteins in vivoCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II–Induced Muscle WastingJournal of the American Society of Nephrology, 2009
- C-Reactive Protein in Heart FailureCirculation, 2005
- Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failureAmerican Journal of Physiology-Cell Physiology, 2004
- Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum LevelsJournal of the American Geriatrics Society, 2002
- Size and strength of the respiratory and quadriceps muscles in patients with chronic asthmaEuropean Respiratory Journal, 1997
- Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.BMJ, 1981
- Fractional catabolic rates of myosin and actin estimated by urinary excretion ofNT-methylhistidine: the effect of dietary protein level on catabolic rates under conditions of restricted food intakeBritish Journal of Nutrition, 1977
- 3-Methylhistidine, a component of actinBiochemical and Biophysical Research Communications, 1967